Hospira Gains Global Biogeneric Rights From Teva

Hospital products and generic drugmaker Hospira Inc said it acquired worldwide rights to a generic version of the white blood-cell boosting drug filgrastim from Teva Pharmaceutical Industries Ltd.
Yahoo! Finance UK & Ireland